Invitrogen™ Human CLEC9A ELISA Kit

Ref.: BL-RE-155154Manufacturer ref.: EH111RBX5 5 x 96 tests
€2,950.00 excl. VAT

Human CLEC9A quantitates human CLEC9A in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human CLEC9A.

Accession number
9830005G06Rik; CD370; CLEC9A; family of lectin-type C 9-member A domains; family of lectin-type C 9-member A domains; group receptor of natural lectin-dendritic cells 1; DNGR1; Dngr-1; heee9341; RGD1562513; UNQ9341; UNQ9341/PRO34046
Dose range
0.12 to 25 ng/mL
Sensitivity of the dosage
0.12 ng/mL
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

Human CLEC9A quantitates human CLEC9A in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human CLEC9A.

Human CLEC9A quantitates human CLEC9A in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human CLEC9A.

CLEC9A is a type C lectin-like receptor in CTLR group V that functions as a d-activation receptor and is expressed on myeloid cell lines. This protein is also expressed on the cell surface and acts as glycosylated dimers that mediate l的enocyteosis, but not phagocytosis (Poulin LF et al, 2010). It facilitates the absorption and presentation of antigens and can provide an appropriate target for the administration of antibody-mediated antigens. CLEC9A is important for transmitting information from necrotic cells to T cells and defines a way through which adaptive immune responses can be initiated in the absence of infection. He recruited Syk to mediate necrosis detection by the main subset of DC involved in the regulation of cross-boot initiation to antigens associated with cells. Signalling via this kinase is done by a new pathway involving CARD9 that induces a variety of cellular responses, including cytokine induction (such as TNF, IL-6, IL-10, IL-23 and IL-2), respiratory bursting and arachidonic acid production. In addition, it induces adaptive TH17 (T-auxiliary type 17) responses in vivo. The expression of CLEC9A is very limited in peripheral blood, being detected only on the DC BDCA3+ and on a small subset of the CD14+ CD16- monocytes. The CLEC9A is used as a new marker to distinguish subtypes of domain controllers.

Sensitivity

Sensitivity of the assay: 0.12 ng/mL.

Measurement range

Dose range: 0.12 to 25 ng/mL.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Target

Target: CLEC9A.

Samples

Type of sample: Plasma, Serum, Surnatant (plasma volume, 50 µl; Serum, 50 µl; Supernatant, 50 µl).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17134859
Specifications
Accession number9830005G06Rik; CD370; CLEC9A; family of lectin-type C 9-member A domains; family of lectin-type C 9-member A domains; group receptor of natural lectin-dendritic cells 1; DNGR1; Dngr-1; heee9341; RGD1562513; UNQ9341; UNQ9341/PRO34046
Dose range0.12 to 25 ng/mL
Sensitivity of the dosage0.12 ng/mL
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)Q6UXN8
Gene symbol(s)CLEC9A
Coefficient of inter-dose variation<12%
Coefficient of intra-dose variation<10%
Contents of kitsPre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity5 x 96 tests
Regulatory statusUse exclusively for research
TargetCLEC9A
Test time1 h 20 min
Physical characteristics
Volume of samplePlasma, 50 µl; Serum, 50 µl; Supernatant, 50 µl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EH111RBX5
Country of originUnited States
A question or a specific configuration?
Contact us for a quote.